İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

SİNAN MERSİN

DOKTOR ÖĞRETİM ÜYESİ

MERSİN ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Hematoloji (İç Hastalıkları)

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 12
  • Proje 0
  • Kitap 0
  • Bildiri 0
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 1 Q2 9 Q3 5 Q4 0
WoS (JCR) Q1 1 Q2 0 Q3 10 Q4 4
TR Index 4 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 1
Ort. yüzdelik 51.4%
Üst %1 payı 0.0%
Üst %10 payı 6.2%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 12 yayın

Scopus (SJR)
Q1 1 Q2 9 Q3 5 Q4 0
WoS (JCR)
Q1 1 Q2 0 Q3 10 Q4 4
TR Index
4 makale

Makale listesi

  1. 2025 Evaluation of contraception methods in chronic myeloid leukemia patients: A Turkish multicenter study Journal of Oncology Pharmacy Practice DOI 10.1177/10781552241280615 YÖKSİS SJR Q3 JCR Q4 OpenAlex 19.7%
  2. 2025 Real-world data on direct oral anticoagulants in BCR::ABL1-negative myeloproliferative neoplasms (MPNs): a multicenter retrospective study on behalf of scientific subcommittee on MPNs for Turkish society of hematology Journal of Thrombosis and Thrombolysis DOI 10.1007/s11239-024-03043-5. YÖKSİS SJR Q2 JCR Q3 OpenAlex 78.1%
  3. 2024 Real-Life Outcomes of Bosutinib in Patients with Chronic Myeloid Leukemia: A Multicenter Nationwide Study from Turkey Blood DOI 10.1182/blood-2024-193433 YÖKSİS SJR Q1 JCR Q1
  4. 2024 Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients Turkish Journal of Hematology DOI 10.4274/tjh.galenos.2024.2023.0430 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex üst %10 OpenAlex 91.2%
  5. 2023 Effects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma Indian Journal of Hematology and Blood Transfusion DOI 10.1007/s12288-022-01574-6 YÖKSİS SJR Q3 JCR Q4 OpenAlex 65.3%
  6. 2021 Serum calprotectin (S100A8/A9) levels as a new potential biomarker of treatment response in Hodgkin lymphoma Wiley DOI 10.1111/ijlh.13559 YÖKSİS SJR Q2 JCR Q3 OpenAlex 75.1%
  7. 2021 Evaluation of Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients Turkish Journal of Hematology DOI 10.4274/tjh.galenos.2021.2020.0555 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 41.9%
  8. 2021 Kronik Lenfositik Lösemide PD-1/PDL1 Ekspresyon Düzeyleri ve Prognostik Önemi Acıbadem Üniversitesi Sağlık Bilimleri Dergisi DOI 10.31067/acusaglik.850893 YÖKSİS TR Index OpenAlex 2.4%
  9. 2019 Yaşlı Akut Lenfositik Lösemi Hastalarının Tedavisinde Standart Tedavi mi? Düşük Yoğunluklu Tedavi mi? Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi DOI 10.22312/sdusbed.497315 YÖKSİS TR Index OpenAlex 8.7%
  10. 2018 Factors affecting inadequate response to HBV vaccine in hemodialysis patients: northeast anatolia survey with six hemodialysis centers Clinical and Experimental Nephrology DOI 10.1007/s10157-018-1676-x YÖKSİS SJR Q2 JCR Q3 OpenAlex 75.2%
  11. 2015 IPSET Thrombosis Better Identifies Thrombosis Free Survival A Turkish Cohort Clinical Lymphoma Myeloma and Leukemia DOI 10.1016/j.clml.2015.02.004 YÖKSİS SJR Q2 JCR Q3 OpenAlex 51.7%
  12. 2025 Real-world data on direct oral anticoagulants in BCR::ABL1-negative myeloproliferative neoplasms (MPNs): a multicenter retrospective study on behalf of scientific subcommittee on MPNs for Turkish society of hematology Journal of Thrombosis and Thrombolysis DOI 10.1007/s11239-024-03043-5 YÖKSİS SJR Q2 JCR Q3 OpenAlex 77.9%
  13. 2024 Evaluation of contraception methods in chronic myeloid leukemia patients: A Turkish multicenter study Journal of Oncology Pharmacy Practice DOI 10.1177/10781552241280615 YÖKSİS SJR Q3 JCR Q4 OpenAlex 19.7%
  14. 2023 Current and emerging tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia in young adults Expert Opinion on Pharmacotherapy DOI 10.1080/14656566.2023.2240702 YÖKSİS SJR Q2 JCR Q3 OpenAlex 14.3%
  15. 2021 Serum calprotectin (S100A8/A9) levels as a new potential biomarker of treatment response in Hodgkin lymphoma International Journal of Laboratory Hematology DOI 10.1111/ijlh.13559 YÖKSİS SJR Q2 JCR Q3 OpenAlex 75.1%
  16. 2019 Factors affecting inadequate response to HBV vaccine in hemodialysis patients: northeast anatolia survey with six hemodialysis centers Clinical and Experimental Nephrology DOI 10.1007/s10157-018-1676-x YÖKSİS SJR Q2 JCR Q3 OpenAlex 75.2%
  17. 2015 IPSET-Thrombosis Better Identifies Thrombosis-Free Survival: A Turkish Cohort Clinical Lymphoma Myeloma and Leukemia DOI 10.1016/j.clml.2015.02.004 YÖKSİS SJR Q2 JCR Q3 OpenAlex 51.7%

Akademisyenlere dön